DOI QR코드

DOI QR Code

Protective Effects of the Ethanol Extract of Viola tianshanica Maxim against Acute Lung Injury Induced by Lipopolysaccharides in Mice

  • Wang, Xue (Xinjiang Key Laboratory for Uighur Medicine, Xinjiang Institute of Materia Medica) ;
  • Yang, Qiao-Li (Xinjiang Key Laboratory for Uighur Medicine, Xinjiang Institute of Materia Medica) ;
  • Shi, Yu-Zhu (Xinjiang Key Laboratory for Uighur Medicine, Xinjiang Institute of Materia Medica) ;
  • Hou, Bi-Yu (Beijing Key Laboratory of Drug Target Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences) ;
  • Yang, Sheng-Qian (Beijing Key Laboratory of Drug Target Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences) ;
  • Huang, Hua (Xinjiang Key Laboratory for Uighur Medicine, Xinjiang Institute of Materia Medica) ;
  • Zhang, Li (Beijing Key Laboratory of Drug Target Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences) ;
  • Du, Guan-Hua (Beijing Key Laboratory of Drug Target Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences)
  • Received : 2017.01.26
  • Accepted : 2017.07.28
  • Published : 2017.09.28

Abstract

Viola tianshanica Maxim, belonging to the Violaceae plant family, is traditionally used in Uighur medicine for treating pneumonia, headache, and fever. There is, however, a lack of basic understanding of its pharmacological activities. This study was designed to observe the effects of the ethanol extract (TSM) from Viola tianshanica Maxim on the inflammation response in acute lung injury (ALI) induced by LPS and the possible underlying mechanisms. We found that TSM (200 and 500 mg/kg) significantly decreased inflammatory cytokine production and the number of inflammatory cells, including macrophages and neutrophils, in bronchoalveolar lavage fluid. TSM also markedly inhibited the lung wet-to-dry ratio and alleviated pathological changes in lung tissues. In vitro, after TSM ($12.5-100{\mu}g/ml$) treatment to RAW 264.7 cells for 1 h, LPS ($1{\mu}g/ml$) was added and the cells were further incubated for 24 h. TSM dose-dependently inhibited the levels of proinflammatory cytokines, such as NO, $PGE_2$, $TNF-{\alpha}$, IL-6, and $IL-1{\beta}$, and remarkably decreased the protein and mRNA expression of $TNF-{\alpha}$ and IL-6 in LPS-stimulated RAW 264.7 cells. TSM also suppressed protein expression of $p-I{\kappa}Ba$ and p-ERK1/2 and blocked nuclear translocation of $NF-{\kappa}B$ p65. The results indicate that TSM exerts anti-inflammatory effects related with inhibition on $NF-{\kappa}B$ and MAPK (p-ERK1/2) signaling pathways. In conclusion, our data demonstrate that TSM might be a potential agent for the treatment of ALI.

Keywords

References

  1. Ya ng J, Qu JM, Summah H, Zhang J, Zhu YG, Jiang HN. 2010. Protective effects of imipramine in murine endotoxin induced acute lung injury. Eur. J. Pharmacol. 638: 128-133. https://doi.org/10.1016/j.ejphar.2010.04.005
  2. B hatia M, Moochhala S. 2004. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J. Pathol. 202: 145-156. https://doi.org/10.1002/path.1491
  3. Wa re LB, Matthay MA. 2000. The acute respiratory distress syndrome. N. Engl. J. Med. 342: 1334-1349. https://doi.org/10.1056/NEJM200005043421806
  4. Ch u X, Song K, Xu K, Zhang X, Song Y, Wang D, et al. 2010. Ceftiofur attenuates lipopolysaccharide-induced acute lung injury. Int. Immunopharmacol. 10: 600-604. https://doi.org/10.1016/j.intimp.2010.02.010
  5. Chen H , Bai C, Wang X. 2010. The value o f the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Rev Respir. Med. 4: 773-783. https://doi.org/10.1586/ers.10.71
  6. Wa ng G, Huang X, Li Y, Guo K, Ning P, Zhang Y. 2013. PARP-1 inhibitor, DPQ, attenuates LPS-induced acute lung injury through inhibiting NF-$\kappa$B-mediated inflammatory response. PLoS One 8: e79757. https://doi.org/10.1371/journal.pone.0079757
  7. Liu YM. 1999. Pharmacography of Uighur, Part 1, pp. 35-37. Xinjiang Science & Technology & Hygiene Publishing House, Urumuqi, China.
  8. Ch inese Pharmacopoeia Commission of Sanitary Ministry of People's Republic of China. 2010. Chinese Pharmacopoeia, Part 1. Chemical Industry Publishing House, Beijing, China.
  9. Ki m YW, Zhao RJ, Park SJ, Lee JR, Cho IJ, Yang CH, et al. 2008. Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-$<{\kappa}$B-dependent iNOS and proinflammatory cytokines production. Br. J. Pharmacol. 154: 165-173. https://doi.org/10.1038/bjp.2008.79
  10. Xi e C, Kang J, Li Z, Schauss AG, Badger TM, Nagarajan S, et al. 2012. The acai flavonoid velutin is a potent antiinflammatory agent: blockade of LPS-mediated TNF-$<{\alpha}$ and IL-6 production through inhibiting NF-$<{\kappa}$B activation and MAPK pathway. J. Nutr. Biochem. 23: 1184-1191. https://doi.org/10.1016/j.jnutbio.2011.06.013
  11. Ki m KS, Cui X, Lee DS, Ko W, Sohn JH, Yim JH, et al. 2014. Inhibitory effects of benzaldehyde derivatives from the marine fungus Eurotium sp. SF-5989 on inflammatory mediators via the induction of heme oxygenase-1 in lipopolysaccharide-stimulated RAW264.7 macrophages. Int. J. Mol. Sci. 15: 23749-23765. https://doi.org/10.3390/ijms151223749
  12. Ki m KH, Kim DH, Jeong N, Kim KI, Kim YH, Lee M, et al. 2013. Therapeutic effect of Chung-Pae, an experimental herbal formula, on acute lung inflammation is associated with suppression of NF-${\kappa}$B and activation of Nrf2. Evid. Based Complement. Alternat. Med. 2013: 1-11.
  13. von Bismarck P, Klemm K, Garcia Wistadt CF, Winoto MS, Schutze S, Krause MF. 2009. Selective NF-${\kappa}$B inhibition, but not dexamethasone, decreases acute lung injury in a newborn piglet airway inflammation model. Pulm. Pharmacol. Ther. 22: 297-304. https://doi.org/10.1016/j.pupt.2009.02.002
  14. Meduri GU, Tolley EA, Chrousos GP, Stentz F. 2002. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am. J. Respir. Crit. Care Med. 165: 983-991. https://doi.org/10.1164/ajrccm.165.7.2106014
  15. Sa n Z, Fu Y, Li W, Zhou E, Li Y, Song X, et al. 2014. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice. Int. Immunopharmacol. 19: 342-350. https://doi.org/10.1016/j.intimp.2014.01.031
  16. Ka lyan KG, Dhamotharan R, Kulkarni NM, Mahat MY, Gunasekaran J, Ashfaque M. 2011. Embelin reduces cutaneous TNF-$\alpha$ level and ameliorates skin edema in acute and chronic model of skin inflammation in mice. Eur. J. Pharmacol. 662: 63-69. https://doi.org/10.1016/j.ejphar.2011.04.037
  17. Tur eyen K, Bowen K, Liang J, Dempsey RJ, Vemuganti R. 2011. Exacerbated brain damage, edema and inflammation in type-2 diabetic mice subjected to focal ischemia. J. Neurochem. 116: 499-507. https://doi.org/10.1111/j.1471-4159.2010.07127.x
  18. Aderem A, Ulevitch RJ. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406: 782-787. https://doi.org/10.1038/35021228
  19. Na ntel F, Denis D, Gordon R, Northey A, Cirino M, Metters KM, Chan CC. 1999. Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation. Br. J. Pharmacol. 128: 853-859. https://doi.org/10.1038/sj.bjp.0702866
  20. Moynagh PN. 2005. The NF-${\kappa}$B pathway. J. Cell Sci. 118: 4589-4592. https://doi.org/10.1242/jcs.02579
  21. Goodman RB, Pugin J, Lee JS, Matthay MA. 2003. Cytokinemediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 14: 523-535. https://doi.org/10.1016/S1359-6101(03)00059-5
  22. As ehnoune K, Strassheim D, Mitra S, Kim JY, Abraham E. 2004. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-${\kappa}$B. J. Immunol. 172: 2522-2529. https://doi.org/10.4049/jimmunol.172.4.2522
  23. Ch en X, Zhang S, Xuan Z, Ge D, Chen X, Zhang J, et al. 2017. The phenolic fraction of Mentha haplocalyx and its constituent linarin ameliorate inflammatory response through inactivation of NF-${\kappa}$B and MAPKs in lipopolysaccharideinduced RAW264.7 cells. Molecules 22: 811. https://doi.org/10.3390/molecules22050811
  24. G uan F, Wang H, Shan Y, Chen Y, Wang M, Wang Q, et al. 2014. Inhibition o f COX-2 a nd P GE2 in LPS-stimulated RAW264.7 cells by lonimacranthoide VI, achlorogenic acid ester saponin. Biomed. Rep. 2: 760-764. https://doi.org/10.3892/br.2014.314
  25. Bose S, Kar N, Maitra R, DiDonato JA, Banerjee AK. 2003. Temporal activation of NF-${\kappa}$B regulates an interferon independent innate antiviral response against cytoplasmic RNA viruses. Proc. Natl. Acad. Sci. USA 100: 10890-10895. https://doi.org/10.1073/pnas.1832775100
  26. C hen F, Kuhn DC, Sun SC, Gaydos LJ, Demers LM. 1995. Dependence and reversal of nitric oxide production on NF-${\kappa}$B in silica and lipopolysaccharide-induced macrophages. Biochem. Biophys. Res. Commun. 214: 839-846. https://doi.org/10.1006/bbrc.1995.2363
  27. Jimi E , Ghosh S. 2005. Role of nuclear factor-${\kappa}B$ in the immune system and bone. Immunol. Rev. 208: 80-87. https://doi.org/10.1111/j.0105-2896.2005.00329.x
  28. S ohn KH, Jo MJ, Cho WJ, Lee JR, Cho IJ, Kim SC, et al. 2012. Bojesodok-eum, a herbal prescription, ameliorates acute inflammation in association with the inhibition of NF-${\kappa}B$-mediated nitric oxide and proinflammatory cytokine production. Evid. Based Complement. Alternat. Med. 2012: 1-12.
  29. Jiang JX, Zhang Y, Ji SH, Zhu P, Wang ZG. 2002. Kinetics of mitogen-activated protein kinase family in lipopolysaccharidestimulated mouse Kupffer cells and their role in cytokine production. Shock 18: 336-341. https://doi.org/10.1097/00024382-200210000-00008
  30. Bondeson J. 1997. The mechanisms of action of diseasemodifying antirheumatic drugs: a review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines. Gen. Pharmacol. 29: 127-150. https://doi.org/10.1016/S0306-3623(96)00419-3
  31. C hoi K, Kim M, Ryu J, Choi C. 2007. Ginsenosides compound K and Rh(2) inhibit tumor necrosis factor-alpha-induced activation of the NF-kappaB and JNK pathways in human astroglial cells. Neurosci. Lett. 421: 37-41. https://doi.org/10.1016/j.neulet.2007.05.017